COVID-19 Research | Hadassah International

Hadassah International Supports the Hadassah Medical Center: More than a Hospital!

Dissolving COVID Blood Clotting

With the onset of the pandemic, some 30 percent of COVID-19 patients suffered blood clots that created lethal blockages in their lungs, kidneys, heart, and brain. Prof. Abd al-Roof Higazi…

Protecting the Yet-to-Be-Born From COVID-19

Hadassah Study Reports Incidence of Myocarditis After Pfizer Vaccine

Study Links Blood Glucose Levels to Risk for Serious Case of COVID-19

...More than a Hospital

Hadassah Study Reveals COVID-19 Vaccine Doesn’t Damage Sperm

Pregnant Mom’s COVID-19 Antibodies Should Protect Her Baby, Too

COVID-19 Patients Recover With New Treatment From Hadassah

Enlivex Reports Top-Line Results for Allocetra™ in Treating COVID-19

Drug Developed by Hadassah Doctor Helps Severely Ill COVID-19 Patients

...More than a Hospital

Using Algorithms, Israeli Start-Up Predicts Who Has COVID-19

...More than a Hospital

Hadassah to Conduct Clinical Trial of Israeli-Made COVID-19 Vaccine

...More than a Hospital

Hadassah Physician-Scientists Are Showcased at Global Press Conference

...More than a Hospital

Hadassah Physician Turns to SodaStream to Ease COVID-19 Patients’ Breathing

...More than a Hospital

First Commercial Antibody Serum Given at Hadassah to COVID-19 Patient

...More than a Hospital

Hadassah Researchers Identify Source of Blood Clots in COVID-19 Patients

COVID-19: Can We Win the War?

...More than a Hospital

Has COVID-19 Changed the Nature of Social Interaction for Good?

...More than a Hospital

“What is Next?” – Hadassah Doctors Bring their COVID-19 Expertise to Russia

On the Way to a Cure for COVID-19: Hadassah’s Researchers Forge Ahead

...More than a Hospital

COVID-19 On The Way to a Cure – Special Zoom Webinar with Prof. Eyal Mishani